CHIRALGEN LTD has a total of 15 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and China. Its main competitors in its focus markets organic fine chemistry, environmental technology and biotechnology are AVECIA BIOTECHNOLOGY INC, WADA TAKESHI and SAMCHULLY PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Japan | 4 | |
#3 | China | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Environmental technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Climate change mitigation in goods production | |
#3 | Special acyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Organic chemistry methods | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Wada Takeshi | 14 |
#2 | Shimizu Mamoru | 11 |
#3 | Saigo Kazuhiko | 4 |
#4 | Oka Natsuo | 1 |
#5 | Mamoru Shimizu | 1 |
#6 | Takeshi Wada | 1 |
#7 | Arai Kouichiro | 1 |
#8 | Kato Yukiko | 1 |
#9 | Umemoto Tadashi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012073857A1 | 2'-o-modified rna | |
JP2011088935A | Optically-active nucleoside 3'-phosphoroamidite for production of phosphorus atom modified nucleotide analog |